Musculoskeletal Disorders in Mountain Runners

Status Completed

Clinical Trial Summary

the study aims to estimate the prevalence of musculoskeletal disorders in a population of runners in the mountains; moreover it proposes to explore the relationship between distance traveled, the difference in height, the training frequency in the week, the shoes worn, the training method, the use of supports and experience of running with musculoskeletal disorders. The secondary objectives of this study are to investigate to which rehabilitative figures the sportsman turns and if the treatments have positive outcomes.

Clinical Trial Description

Running is one of the most popular forms of exercise in the world. The prevalence of musculoskeletal disorders in street runners has already been extensively studied and is about 55% of those affected. In recent years, more and more runners paid their attention to mountain running where, the different types of terrain and the important differences in height require a different musculoskeletal effort. In the literature there are few studies that have investigated the prevalence of disorders, risk factors and protective factors on these runners. The mountain running performed with regularity and method is certainly a healthy activity for individuals, but it is not free from injuries due to several factors, such as long distance, significant differences in level and uneven terrain. It is not clear whether these factors can influence the onset of skeletal muscle disorders. The study aims to estimate the prevalence of musculoskeletal disorders in this population of mountain runners; moreover it proposes to explore in this population the relationship between distance traveled, the difference in height, the training frequency in the week, the shoes worn, the training method, the use of supports and experience of running with musculoskeletal disorders. Moreover, the study wants to investigate to which rehabilitative figures the sportsman turns and if the treatments have positive outcomes. Inclusion criteria are: age over 18, be a participant of at least one trail, understand the Italian language, to have signed informed consent. Recruitment: all participants in mountain races will be invited to reply to the attached questionnaire anonymously when the race bib is picked up. The runners will be free to participate or not in the survey, without the choice can affect the results of the race in any way and can create situations of subjection to the organization. ;

Study Design

Related Conditions & MeSH terms

Musculoskeletal Diseases

Clinical Trial Details

NCT number	NCT03636425
Study type	Observational
Source	University of Bologna
Contact
Status	Completed
Phase
Start date	August 30, 2018
Completion date	January 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04976972` - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation	N/A
Recruiting	`NCT05546541` - Epidemiology and Nutrition
Completed	`NCT05071469` - Comparison of Two Different Treatment Methods	N/A
Completed	`NCT05041400` - Distribution of Knee Isokinetic Angle-specific Moments and Ratios	N/A
Not yet recruiting	`NCT06216028` - Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis	Phase 3
Not yet recruiting	`NCT04932993` - Writing Down Goals	N/A
Completed	`NCT02944448` - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee	Phase 2
Completed	`NCT02269254` - Persona Versus NexGen	N/A
Completed	`NCT02256098` - RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA	N/A
Completed	`NCT02257489` - Phase 1 Study of ACE-083 in Healthy Subjects	Phase 1
Completed	`NCT01979731` - Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders	N/A
Active, not recruiting	`NCT01440153` - Additional Exercise Program in Professional Dancers	N/A
Completed	`NCT00968266` - Improving Beliefs About Medication in Patients With Rheumatoid Arthritis	N/A
Completed	`NCT05222126` - Efficacy of Ultrasound-Guided Hydrodissection in Carpal Tunnel Syndrome	N/A
Completed	`NCT05062694` - Physical Therapy Management Of The Patient With Central Sensitization
Recruiting	`NCT05564182` - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain	N/A
Completed	`NCT04009369` - Impacts of Physiotherapy Services in a Quebec Emergency Department	N/A
Completed	`NCT05561452` - The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome	N/A
Recruiting	`NCT05432609` - Standardization and Reproducibility Regarding Scanning Procedures and Measurements of Weight-bearing Cone Beam CT in the Lower Extremity
Completed	`NCT04959162` - The Effect of Theoretical Knowledge on Resident's Practical Performance in Musculoskeletal Ultrasound	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.